Scientists say they have identified a way to stop a well-known signaling molecule from eroding bones and causing joint inflammation, a discovery that could potentially reverse conditions such as rheumatoid arthritis and osteoporosis. Researchers at the University of Rochester Medical Center say that changing the way a pathway known as the nuclear factor kappa B complex (NF-κB) may keep the two molecules (TNFα and RANKL) from breaking down too much bone and inflaming bones.
Read moreIf you are here at OsteoporosisConnection.com you are aware of osteoporosis, osteopenia and some of the other metabolic bone disorders;... Read more »
Boniva®, Fosomax®, Actonel®, Forteo®… Evista®? If you’ve been diagnosed with osteoporosis or osteopenia, and changes in diet and... Read more »
An osteoporosis controversy, centered on the affordability of DXA scans, a common osteoporosis screening test, is heating up in the... Read more »
According to Dr. Susan Ott, Professor of the University of Washington Bone Physiology Course, "Bisphosphonates are NOT APPROVED for... Read more »
Are you taking an osteoporosis medication and seeing very little improvement? If so, this is very frustrating because we do all we're... Read more »
Source: ADAM Encyclopedia
Thin bones Treatment The goals of osteoporosis treatment are to: Control pain from the disease Slow down or stop bone loss ... Read more »
Legislation designed to protect patient access to osteoporosis care has been introduced in the U.S. Congress. The Medicare Fracture Prevention and... Read more »
SAN FRANCISCO (Ivanhoe Broadcast News) -- About 10 million Americans suffer from osteoporosis. The condition is characterized by low bone density,... Read more »
The osteoporosis med Fosamax and other bisphosphonates have been linked to jaw bone loss, but one reader wants to know if the condition can be... Read more »
An analysis of 621 studies on more than 135,000 patients has confirmed weight-loss surgery's ability to reverse Type 2 diabetes. Researchers say that... Read more »